SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.48+1.4%Nov 14 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1022)6/10/2005 11:52:41 AM
From: Jibacoa  Read Replies (2) of 3722
 
ABRX Is trying to find support at the $4 level, but it is still long way from trying to start closing its May 19 down-gap.(For that it will need to close above $11.<g>)

The stock came down yesterday when ABRX announced that it was going to cut more workers.(It had already announced in May that it was going to trim about half of its workforce.)

In May it also announced that it was suspending all shipments and initiating a full product recall because of quality control problems and that is what triggered the downgap.<g>.

ABRX doesn't have any significant LTD and reportedly has more than $16M in cash. Although I am not in favor of "bottom fishing", it seems the R/R on ABRX is not bad at this level,since the worse news are probably over.<g>

bigcharts.marketwatch.com

Message 21355089

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext